Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients.

Ali Afshar OmeriehTim Holland-LetzFrederik L GieselClemens KratochwilWalter MierSabine HaufeNils DebusMatthias EderMichael EisenhutMartin SchäferOliver NeelsMarkus HohenfellnerKlaus KopkaHans-Ulrich KauczorJürgen DebusUwe Haberkorn

Published in: European journal of nuclear medicine and molecular imaging (2017)

68Ga-PSMA-11 PET/CT detects tumour lesions in a high percentage of patients with recurrent PCa. Tumour detection is clearly associated with PSA level and ADT. Only a tendency for an association without statistical significance was found between higher GSC and a higher probability of a pathological PET/CT scan. No associations were found between a pathological 68Ga-PSMA-11 PET/CT scan and patient age, amount of injected activity, PSADT or PSAVel.

Keyphrases

pet ct
prostate cancer
positron emission tomography
computed tomography
end stage renal disease
radical prostatectomy
ejection fraction
newly diagnosed
peritoneal dialysis
case report
patient reported